Clinical Trials Logo

Filter by:
NCT ID: NCT02016521 Completed - Clinical trials for Exercise Performance

Cooling Fabrics and Exercise Performance in Endurance Athletes

Start date: January 2014
Phase: N/A
Study type: Interventional

In humans, the primary means of cooling the body during exercise is through the evaporation of sweat from the skin surface. Clothing represents a layer of insulation that hinders the evaporation of sweat from the surface of the skin. It follows that clothing that imposes the least amount of resistance to evaporative heat loss may prove beneficial to the thermoregulatory, physiological and perceptual response to exercise, particularly in elite endurance-trained athletes. Thus, the purpose on this study is to examine the influence of wearing a sportswear garment made of a fabric (100% nylon) with superior evaporative characteristics on detailed thermoregulatory, cardiorespiratory, metabolic and perceptual responses to maximal exercise testing at normal room temperature and relatively humidity in a group of 25 endurance-trained cyclists and triathletes aged 20-60 years. It is hypothesized that wearing a garment made of 100% nylon will improve exercise performance (e.g., exercise endurance time) and that this improvement will reflect improvements in thermoregulatory, cardiorespiratory, metabolic and perceptual responses to exercise. Athletes will be recruited via contact with coaches of the McGill University Cycling and Triathlon teams as well as through contact with coaches of competitive cycling and triathlon teams/training groups in the Montreal and surrounding area. Initial contact will consist of a thorough explanation of the study procedures and pre-screening for the inclusion/exclusion criteria prior to study consent by the Principal Investigator and/or his delegate, either in person or by telephone or email. Eligible participants will visit McGill's Clinical Exercise & Respiratory Physiology Laboratory on 3 separate occasions over a period of 10-14 days. Visit 1 will include a maximal incremental bicycle exercise test for familiarization purposes and to determine maximal power output (MPO). Visits 2 and 3 will include a constant-power-output bicycle exercise test at 85% MPO under one of two conditions, in randomized order: (1) while wearing a garment made of 100% polyester, i.e., placebo; and (2) while wearing a garment made of 100% nylon, i.e., cooling fabric. At rest and during exercise at visits 2 and 3, detailed assessments of core body temperature will be made using a temperature sensor placed into the esophagus, while skin temperature and other physiological and perceptual parameters will be measured using standard techniques.

NCT ID: NCT02016482 Completed - Plaque Psoriasis Clinical Trials

A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis

Start date: January 2014
Phase: Phase 3
Study type: Interventional

This study is being conducted to assess the safety and efficacy of adalimumab in subjects with nail psoriasis.

NCT ID: NCT02015520 Completed - Clinical trials for Rheumatoid Arthritis

Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis

Start date: June 2012
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to identify an appropriate dose of study medication.

NCT ID: NCT02015481 Completed - Clinical trials for Oculopharyngeal Muscular Dystrophy

Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients

HOPEMD
Start date: February 2014
Phase: Phase 2
Study type: Interventional

The Purpose of this study is to assess the Safety, Tolerability and Efficacy of Intravenous Cabaletta® in Oculopharyngeal Muscular Dystrophy (OPMD) Patients.

NCT ID: NCT02015429 Completed - Obesity Clinical Trials

Effect of Yellow Pea Protein and Fibre Added to a High-carb Meal on Glycemic Response and Food Intake

Start date: December 2007
Phase: N/A
Study type: Interventional

The investigators hypothesized that consuming isolated yellow pea fibre or protein, alone to together, as part of a high-carbohydrate pasta meal, would reduce the blood glucose response to the meal compared to a meal without yellow pea components and reduce food intake at a meal served 2 hours later.

NCT ID: NCT02015208 Completed - Clinical trials for Chronic Lymphocytic Leukemia

Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia

Start date: April 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if Ruxolitinib, an inhibitor of cytokine-signaling, is effective in the treatment of patients with Chronic Lymphocytic Leukemia for whom conventional chemotherapy is either too toxic or ineffective.

NCT ID: NCT02015182 Completed - Clinical trials for Transversus Abdominis Plane Block

Bupivacaine Pharmacokinetics Following TAP Block

Start date: September 2011
Phase: N/A
Study type: Observational

The aims of this study are to determine population PK parameters of bupivacaine in children following TAP block using a population-based PK approach, and to evaluate the influence of patient covariates on drug disposition.

NCT ID: NCT02014922 Completed - Dry Eye Syndromes Clinical Trials

A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)

DUNLIN
Start date: December 2013
Phase: Phase 4
Study type: Interventional

Dry eye is a very common condition that most often affects women and the elderly, and can be caused when the eyes do not produce enough tears, or when the tears evaporate too quickly. Although there isn't a simple cure for dry eye, there are numerous products on the market that attempt to help relieve some of the discomfort caused by this condition. Some of these products include artificial tears, omega-3 supplements, and/or anti-inflammatory medications. The purpose of this study is to evaluate the performance of a combination of TheraTears® products, and to compare them with the product(s) you have been using.

NCT ID: NCT02014441 Completed - Melanoma Clinical Trials

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

Start date: April 7, 2014
Phase: Phase 2
Study type: Interventional

The primary objective was to estimate the proportion of participants with detectable talimogene laherparepvec deoxyribonucleic acid (DNA) in the blood and urine at any time after administration of talimogene laherparepvec within the first 3 cycles.

NCT ID: NCT02014233 Completed - Muscle Strength Clinical Trials

Short Term Omega-3 Supplementation on Performance

Start date: June 2013
Phase: N/A
Study type: Interventional

Nerves are the rate limiting factor that control muscle function. However, it is unknown if a nutritional supplement can change the nerve-muscle interaction, and therefore alter human performance. This study will be the first to examine the effects of omega-3 supplementation on neuromuscular function in trained individuals.